Laboratory Peptide Documentation: How to Read HPLC Overlay Results on Peptide COAs (Australia)

What does a sample-versus-reference HPLC overlay show on a peptide COA?

A sample-versus-reference overlay is a chromatographic figure in which at least two detector traces share a common time axis. In peptide COA documentation the usual pair is the test-sample trace and the reference-standard trace acquired under the same reversed-phase HPLC method. Some laboratories add a blank or a system-suitability solution as a third trace. The figure documents identity and comparability: a reviewer can see whether the principal peak of the lot co-elutes, within the method's documented window, with the principal peak of the named standard, and whether the peak envelope is similar. The overlay does not confirm amino-acid sequence, counter-ion identity, water content or related-substance percentages.

Display conventions matter. True overlays superimpose traces on one set of axes. Stacked plots place traces in separate panels with aligned time axes. Offset overlays shift one trace vertically so both envelopes remain visible. Each convention is legitimate if the COA states which traces are present, which colour or line style belongs to which vial, and whether any vertical offset has been applied. A figure without a legend is not interpretable laboratory peptide documentation and should be returned for re-issue rather than annotated from memory.

The chemical meaning of an overlay is limited to the detection channel used. A 214 nm or 220 nm ultraviolet trace documents peptide-bond absorbance. A 280 nm trace documents aromatic side-chain absorbance and is uninformative for sequences that lack those residues. A mass-spectrometric total-ion chromatogram is a different channel and must not be read as the ultraviolet overlay. When both channels appear in the same PDF, confirm that the time axes are comparable and that the method identifier on each page is the same. Channel mismatch is a documentation defect, not evidence that two orthogonal methods have been completed.

Which header fields must concord before laboratory peptide documentation is readable?

Before any peak on an overlay is treated as the lot of interest, the figure must be tied to the same identifiers as the vial and the certificate summary. Minimum concordance fields are material name, lot or batch number, sample or LIMS identifier, method identifier and version, column description, detection wavelength and bandwidth, gradient programme or isocratic composition, instrument identifier, date of acquisition, and the reference-standard lot. If the overlay PDF is a generic method figure with no lot number, it is not batch documentation and cannot be authorised against a named vial.

Field-by-field reading of experimental records is an information-science practice, not a visual impression of a plot. Richmond's 1967 suggestions on how to read experimental material in information science emphasise inspecting the conditions under which data were produced before interpreting the result. Applied to peptide COAs, the overlay is unreadable until method and sample identifiers are confirmed. Australian documentation practice likewise requires locating the correct catalogue record before treating a figure as evidence, a point illustrated by Caviere's 2017 documentation about Atlas of Living Australia tools: how to find information.

Practical checks: the lot number on the overlay header equals the lot on the COA cover sheet and the vial label; the method ID equals the HPLC conditions table; the wavelength equals the reporting channel used for area-percent purity; the reference-standard lot equals the identity specification. Mismatches are documentation defects. They do not automatically mean the chemistry is wrong; they mean the file cannot yet be authorised as belonging to that vial. Where suppliers ship from local Australian stock with tracked dispatch, the dispatch note's lot number should be the same string as the overlay lot number. Truncated or family-level lot codes are not concordance. Two acquisition dates for the same lot are acceptable; two lots are not.

How should retention-time match and peak-apex delta be read on an overlay?

Retention-time match is the quantitative counterpart of a visual overlay. The COA should report the retention time of the principal peak in the sample, the retention time of the principal peak in the reference standard, and either an absolute difference in minutes or a relative retention time. An identity window belongs in the specification table, not in the reviewer's eye. If the overlay looks aligned but no numbers are reported, the identity conclusion is not documented and should be listed as an open question on the batch record.

Peak apex is the usual reporting point. Peak start, peak end and peak centroid are different coordinates and must not be mixed. When the sample peak is broader than the standard peak, the apices may still coincide while the sample peak start falls outside a narrow window defined on the standard. That is a peak-shape or loading question, not automatic identity failure, but it should be recorded. A sample apex clearly outside the documented window is an identity discrepancy even if a thick overlay line makes the peaks look merged. Reviewers should compare numbers first and use the figure only to see whether the tabulated peaks are the ones actually plotted.

Relative retention time (RRT) is the sample retention time divided by the standard retention time from the same sequence, or versus a named marker. Overlay figures that have been time-aligned by software can hide absolute drift. If traces were aligned, read the tabulated retention times, not the aligned picture, when checking the identity window. Alignment is a display operation, not a chromatographic result. If the overlay x-axis is in column volumes or in percent strong solvent, request a time-based chromatogram. The supplier's window, the laboratory's window and the observed delta are three separate values and should all be recorded in laboratory peptide documentation.

How to read HPLC results on a peptide COA overlay versus the purity table

An overlay answers a different question from a purity table. The overlay asks whether the principal peak of the sample is chromatographically comparable to the principal peak of the reference standard. The area-percent table asks what fraction of the integrated peak area in the sample chromatogram is assigned to the principal peak after stated exclusions such as solvent front, known counter-ion, and peaks below the reporting threshold. A coincident overlay can accompany a low area-percent purity if related substances are present at low height. A high area-percent purity can accompany a failed identity window if the principal peak is not the intended peptide. The two results are orthogonal fields and must be filed as such.

Structured reading separates the question a figure can answer from the question a table can answer. Darzins and colleagues, in the Medical Journal of Australia in 1992 on how to read a journal article, treat separation of claims from supporting data as basic reading discipline. The same discipline applies to COAs: a clean overlay does not replace a missing impurity table, and a high purity number does not replace a missing identity comparison. Bulduk and colleagues in 2017 likewise stress that numerical results have to be read inside the reporting framework that produced them, not as free-floating scores detached from method and threshold.

Related substances are often invisible on overlays scaled to the main-peak apex. If the main peak is 1000 mAU and a related substance is 5 mAU, a full-scale overlay hides the impurity in the baseline thickness. Use the sample chromatogram at an expanded absorbance scale, or the related-substances peak table with relative retention times. Overlay height ratios must not be converted into content, because different concentrations and chromatographic loads make heights incomparable. Area-percent purity is not an assay against a reference standard, and the overlay is not a calibration curve.

Which overlay display artefacts are commonly misread as chemistry?

Several display operations create the appearance of chemical agreement or disagreement that is not present in the raw data. Independent auto-scaling of the y-axis forces both main peaks to the same height regardless of concentration or chromatographic load. Independent auto-scale is appropriate for comparing peak shape and retention time; it is inappropriate for comparing response. If the COA does not state whether a common y-scale or independent auto-scale was used, height comparisons on the overlay are not documented and should not be transcribed into the batch record as quantitative agreement.

Time-axis alignment can conceal retention drift. Baseline offset, blank subtraction and smoothing can conceal early-eluting material or create apparent shoulders. A subtracted blank that does not belong to the same sequence as the sample is not a valid baseline. Heavy smoothing can merge a partially resolved related substance into the main peak on the overlay while the unsmoothed peak table still lists two peaks. Detector saturation flattens the sample apex while the standard, at lower load, remains Gaussian; that is an integration and loading problem, not a visual purity result, and it should be checked against absolute area and height in the peak table.

Wrong-trace overlays are a documentation failure. Common errors include overlaying the system-suitability solution instead of the lot sample, overlaying a previous lot, overlaying a different wavelength channel, or overlaying a chromatogram from a different method version. These errors are caught only by header concordance. Sheehan's 1995 essay on how (not) to read is a caution against treating a labelled text as if it automatically discloses its subject; an overlay still has to be checked against vial identifiers. Keep a short artefact checklist: y-scale mode, time alignment, blank subtraction, smoothing, traces identified by vial ID, and detector linearity. Any item not supported by a header field remains an open question.

How should Australian laboratories file HPLC overlay chromatograms with batch records?

Once the overlay has been read, it must be stored so that a later auditor can recover the same figure against the same vial. The batch record should cite the COA document identifier and revision, the PDF page number of the overlay, the chromatogram or LIMS run identifier, the sample vial identifier, the reference-standard lot, the method identifier and version, the date of acquisition, the analyst, and the reviewer who authorised the file. If the supplier issues a multi-page HPLC package, the overlay page must not be detached from the peak table and the conditions table, because concordance cannot be reconstructed from an orphan figure.

Filing is part of reading. Murray's 2002 review of how publishing structures change the way we read is a reminder that the container of a result shapes what later readers can verify. A cropped screenshot of an overlay without headers is not a verifiable container. Australian laboratories should retain the supplier PDF as issued, plus their own concordance checklist, rather than a re-drawn figure that drops method identifiers.

When comparing Australian research-peptide suppliers, ask whether each lot is accompanied by overlay chromatograms that survive the concordance checks above, together with tracked dispatch records that repeat the same lot number. Local AU stock allows the lot on the shelf to be matched to the lot on the COA without an extra transcription step. Materials remain research-use laboratory reagents. If an overlay is missing, request it as a documentation amendment. A single-trace sample chromatogram can support purity integration; it cannot support a sample-versus-reference overlay unless the standard chromatogram from the same sequence is also supplied. Do not infer a result the PDF does not contain.

Apply this checklist to documented stock

You now have a practical way to read purity figures, method notes, and lot traceability. When you source materials, hold suppliers to that same checklist — ClaraScience issues batch documentation with every order and dispatches from Australian warehouses with Express tracked shipping.

Start with a retail order to review documentation end-to-end, or register for wholesale if you restock multiple compounds.

Frequently asked questions

Does a sample-versus-reference overlay replace tabulated HPLC purity on a peptide COA?

No. The overlay documents chromatographic comparability of the principal peak to a named reference standard. Area-percent purity is calculated from the integrated sample chromatogram after stated exclusions. A coincident overlay can sit beside a low area-percent result if related substances are small in height, and a high area-percent result can sit beside a failed identity window. File both fields as laboratory peptide documentation for research-use lots.

What if the overlay looks aligned but tabulated retention times differ?

Treat the table as the identity result and the overlay as a display. Software time-alignment can hide absolute drift. Record sample retention time, standard retention time, delta or relative retention time, and whether alignment was applied. If units are missing or the x-axis is percent strong solvent rather than minutes, request a time-based chromatogram. Do not authorise identity from the picture alone.

Can a ultraviolet overlay confirm amino-acid sequence?

No. A ultraviolet overlay documents retention-time comparability and peak-envelope similarity on the stated detection channel. Sequence confirmation requires orthogonal mass-spectrometric evidence such as intact mass and, where used, fragment-ion mapping. State in the batch record which identity tests were actually supplied, and do not extend the overlay beyond that scope.

Which identifiers must match before an Australian laboratory files the overlay?

Material name, lot number, sample or LIMS identifier, method identifier and version, detection wavelength, reference-standard lot, and vial label must be the same strings. The tracked-dispatch note should repeat the same lot number as local AU stock. Truncated or family-level codes are not concordance and should be raised as a documentation amendment before the file is authorised.

What should a laboratory request if the COA has a purity table but no overlay?

Request the sample and reference-standard chromatograms from the same sequence as a documentation amendment. A single-trace sample chromatogram supports integration; it does not support a sample-versus-reference overlay. Until the overlay, or tabulated retention-time match plus orthogonal mass confirmation, is on file, identity documentation is incomplete. Do not reconstruct an overlay from unrelated PDFs.

References

1. DOI:10.1002/asi.5090180408 — Suggestions on how to read experimental material in information science — American Documentation — 1967
2. DOI:10.3897/tdwgproceedings.1.19941 — Documentation about Atlas of Living Australia tools: how to find information — Proceedings of TDWG — 2017
3. DOI:10.5694/j.1326-5377.1992.tb137249.x — 13. How to read a journal article — Medical Journal of Australia — 1992
4. DOI:10.7816/ulakbilge-05-15-06 — HOW TO BE READ PIAAC RESULTS FOR ADAPTATION TO NEW AGE? — Ulakbilge Dergisi — 2017
5. DOI:10.5840/acpq199569241 — How (Not) To Read Heidegger — American Catholic Philosophical Quarterly — 1995
6. DOI:10.1177/1329878x0210300127 — Review: The Business of Books: How International Conglomerates Took over Publishing and Changed the Way We Read — Media International Australia — 2002

Research use only

This article is provided for laboratory research and educational purposes only. Products referenced are not for human or veterinary use. ClaraScience makes no therapeutic, medical, or efficacy claims, and nothing here constitutes medical advice.